Loading...
XASXALX
Market cap4.15bUSD
Dec 20, Last price  
4.58AUD
1D
-0.22%
1Q
-3.38%
Jan 2017
-6.91%
IPO
601.16%
Name

Atlas Arteria Group

Chart & Performance

D1W1MN
XASX:ALX chart
P/E
25.93
P/S
49.59
EPS
0.18
Div Yield, %
8.73%
Shrs. gr., 5y
0.02%
Rev. gr., 5y
0.24%
Revenues
134m
+13.33%
94,724,00087,460,00089,595,000890,0001,466,0002,212,0002,694,00083,225,000132,377,999167,763,000104,556,000100,515,000118,241,000134,000,000
Net income
324m
+21.18%
-142,488,000-289,489,000-124,435,0001,423,469,000-50,561,00085,082,000225,109,000519,583,00059,852,000-9,821,000-99,210,000163,697,000266,959,000323,500,000
CFO
85m
-82.11%
66,952,00044,917,00045,255,00010,904,000-24,554,000-41,723,000-15,576,00018,120,00023,140,000314,628,00025,438,00040,031,000473,499,00084,700,000
Dividend
Sep 24, 20240.2 AUD/sh
Earnings
Feb 27, 2025

Profile

Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in 22-kilometer toll road investors partnership II (TRIP II), the concessionaire for Dulles Greenway toll road located in Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.
URL
https://www.atlasarteria.com/
IPO date
Jan 25, 2010
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
134,000
13.33%
118,241
17.64%
100,515
-3.86%
Cost of revenue
150,800
141,589
125,430
Unusual Expense (Income)
NOPBT
(16,800)
(23,348)
(24,915)
NOPBT Margin
Operating Taxes
3,700
3,191
(35,767)
Tax Rate
NOPAT
(20,500)
(26,539)
10,852
Net income
323,500
21.18%
266,959
63.08%
163,697
-265.00%
Dividends
(580,400)
(388,402)
(273,320)
Dividend yield
6.91%
4.05%
2.72%
Proceeds from repurchase of equity
(200)
3,027,691
BB yield
0.00%
-31.57%
Debt
Debt current
101,700
100,429
92,747
Long-term debt
1,644,300
1,634,904
1,556,547
Deferred revenue
14,700
25,458
24,486
Other long-term liabilities
52,000
36,425
25,977
Net debt
(4,105,800)
(4,106,247)
(1,398,429)
Cash flow
Cash from operating activities
84,700
473,499
40,031
CAPEX
(800)
(357)
(1,466)
Cash from investing activities
631,700
(3,012,453)
304,048
Cash from financing activities
(673,000)
2,580,525
(374,712)
FCF
191,461
(259,581)
7,200
Balance
Cash
305,300
275,899
229,389
Long term investments
5,546,500
5,565,681
2,818,334
Excess cash
5,845,100
5,835,668
3,042,697
Stockholders' equity
6,235,600
6,490,472
3,497,994
Invested Capital
2,148,300
2,426,120
2,130,211
ROIC
0.52%
ROCE
EV
Common stock shares outstanding
1,452,610
1,450,834
1,450,834
Price
5.78
-12.56%
6.61
-4.48%
6.92
6.46%
Market cap
8,396,087
-12.45%
9,590,011
-4.48%
10,039,769
6.46%
EV
4,290,287
5,483,764
8,641,340
EBITDA
52,400
42,897
36,565
EV/EBITDA
81.88
127.84
236.33
Interest
96,500
88,999
82,688
Interest/NOPBT